Loading…

Lanxess announced the sale of its 40.94% stake in the Envalior joint venture to Advent International for up to US$1.4 billion. The transaction is effective from April 1, 2026, with a base purchase price of about US$1.42 billion.
“German specialty chemicals company Lanxess has decided to sell its remaining stake in the Envalior joint venture to partner Advent International, with the transaction valued at up to US$1.4 billion.”sustainabilitymea.com
Summarized from public sources; check the original articles before acting on it.